NASDAQ · Biotechnology

Lunai Bioworks Inc. (RENB) Stock

$1.42 +0.00% NASDAQ: RENB Healthcare

Lunai Bioworks, Inc. functions as a pre-clinical stage biotechnology enterprise, concentrating its efforts on pioneering genetically modified cell and immunotherapeutic platforms.

Valuation

MetricValue
Price$1.42
Market Cap$32.92M
P/E Ratio0.67
P/B Ratio-3.72
P/S Ratio170.61
EPS (TTM)$2.12
52-Week High$21.00
52-Week Low$1.12
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE892.52%
ROA-2225.00%
ROCE900.00%
Gross Margin60.85%
Operating Margin—
Net Margin—
Debt/Equity-0.15
Current Ratio0.19

Annual Financials (USD)

Metric20212022202320242025
Revenue$0$0$0$0$0
Operating Profit$-23.0M$-116.0M$-39.0M$-82.0M$-189.0M
Net Profit$-27.0M$-113.0M$-40.0M$-81.0M$-178.0M
EPS$-5.70$-21.60$-7.10$-8.40$-1.08
Op Margin—————

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$190.0M$85.0M$58.0M$163.0M$8.0M
Total Liabilities$15.0M$12.0M$12.0M$31.0M$30.0M
Cash$21.0M$9.0M$2.0M$0$0
Borrowings$7.0M$7.0M$6.0M$4.0M$10.0M

Latest News

Zverev, Auger-Aliassime exit star-short Montreal Masters AFP · Aug 6, 2026 Once-popular pizza chain closed over 100 restaurants TheStreet · Aug 6, 2026 Cytek Biosciences Q2 Earnings Call Highlights MarketBeat · Aug 6, 2026 DoorDash Q2 Earnings Call Highlights MarketBeat · Aug 6, 2026 Cirrus Logic Q1 Earnings Call Highlights MarketBeat · Aug 6, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-21.0M$-16.0M$-12.0M$-11.0M$-8.0M
Investing Cash Flow$0$0$0$-1.0M$0
Financing Cash Flow$0$0$2.0M$-1.0M$-1.0M
Net Cash Flow$12.0M$-11.0M$-7.0M$-2.0M$0
Free Cash Flow$-21.0M$-16.0M$-12.0M$-11.0M$-8.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.00
EV / EBITDA-0.23
FCF Yield-15.98%
Quick Ratio0.19
Interest Coverage814.53
Return 1Y—
Return 3Y—
Return 5Y—

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ALLKAllakos Inc. $0.33 +0.22% -0.25 $29.74M 0.00%
ANGNAngion Biomedica Corp. $1.00 +0.00% -0.42 $30.11M 0.00%
FRLNFreeline Therapeutics Holdings plc $6.49 +0.15% -0.29 $28.28M 0.00%
GRCE $2.37 +3.04% -2.26 $38.57M 0.00%
IRDOpus Genetics, Inc. $3.32 +7.63% -2.35 $273.71M 0.00%

About Lunai Bioworks Inc.

Lunai Bioworks, Inc. functions as a pre-clinical stage biotechnology enterprise, concentrating its efforts on pioneering genetically modified cell and immunotherapeutic platforms. These advanced technologies are aimed at providing treatments for a range of infectious diseases and oncological conditions. The company's development pipeline features several candidates, specifically ENOB-HV-01, ENOB-HV-11, ENOB-HV-12, ENOB-DB-01, ENOB-DC-01, ENOB-DC-11, and ENOB-DC-21. Founded on January 18, 2011, by Rene Sindlev and Serhat Gumrukcu, Lunai Bioworks maintains its corporate base in Los Angeles, California.

Lunai Bioworks Inc. is headquartered in US.

Lunai Bioworks Inc. (RENB) stock trades at $1.42 with a market capitalization of $32.92M. The stock is valued at a price-to-earnings (P/E) ratio of 0.67, price-to-book of -3.72, price-to-sales of 170.61. Over the past 52 weeks the stock has ranged between $1.12 and $21.00, and currently trades 93.2% below its 52-week high.

On profitability, Lunai Bioworks Inc. generates a return on equity (ROE) of 892.52% — well above the market average, a sign of a high-quality business, return on capital employed of 900.00%.

Official website: renovarogroup.com

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides